These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19919870)

  • 1. Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans.
    Bordicchia M; Battistoni I; Mancinelli L; Giannini E; Refi G; Minardi D; Muzzonigro G; Mazzucchelli R; Montironi R; Piscitelli F; Petrosino S; Dessì-Fulgheri P; Rappelli A; Di Marzo V; Sarzani R
    Metabolism; 2010 May; 59(5):734-41. PubMed ID: 19919870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients.
    Sarzani R; Bordicchia M; Marcucci P; Bedetta S; Santini S; Giovagnoli A; Scappini L; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Rappelli A
    Metabolism; 2009 Mar; 58(3):361-7. PubMed ID: 19217452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.
    Nannipieri M; Bonotti A; Anselmino M; Cecchetti F; Madec S; Mancini E; Baldi S; Santini F; Pinchera A; Rossi M; Ferrannini E
    Int J Obes (Lond); 2007 Dec; 31(12):1843-8. PubMed ID: 17607322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese.
    Bennetzen MF; Nielsen TS; Paulsen SK; Bendix J; Fisker S; Jessen N; Lund S; Richelsen B; Pedersen SB
    Eur J Clin Invest; 2010 Feb; 40(2):121-6. PubMed ID: 20039929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity.
    Kempf K; Hector J; Strate T; Schwarzloh B; Rose B; Herder C; Martin S; Algenstaedt P
    Horm Metab Res; 2007 Aug; 39(8):596-600. PubMed ID: 17712725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
    Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
    Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women.
    Goedecke JH; Wake DJ; Levitt NS; Lambert EV; Collins MR; Morton NM; Andrew R; Seckl JR; Walker BR
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):81-7. PubMed ID: 16817824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue.
    Sarzani R; Bordicchia M; Marcucci P; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Rappelli A
    J Hum Hypertens; 2010 Mar; 24(3):213-9. PubMed ID: 19536167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia.
    Dinu IR; Popa SG; Moţa M; Moţa E; Stănciulescu C; Ioana M; Cruce M
    Rom J Morphol Embryol; 2011; 52(3):791-5. PubMed ID: 21892520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth weight and gender determine expression of adipogenic, lipogenic and adipokine genes in perirenal adipose tissue in the young adult sheep.
    Muhlhausler BS; Ritorto V; Schultz C; Chatterton BE; Duffield JA; McMillen IC
    Domest Anim Endocrinol; 2008 Jul; 35(1):46-57. PubMed ID: 18308504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
    Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
    Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms.
    Engl J; Sturm W; Sandhofer A; Kaser S; Tschoner A; Tatarczyk T; Weiss H; Tilg H; Patsch JR; Ebenbichler CF
    Eur J Clin Invest; 2008 Apr; 38(4):238-44. PubMed ID: 18312420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
    Catalán V; Gómez-Ambrosi J; Rotellar F; Silva C; Gil MJ; Rodríguez A; Cienfuegos JA; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease.
    Cappellano G; Uberti F; Caimmi PP; Pietronave S; Mary DA; Dianzani C; Micalizzi E; Melensi M; Boldorini R; Nicosia G; Crosio E; Chiocchetti A; Aina F; Prat M; Dianzani U; Vacca G; Ariatti C; Grossini E
    Can J Cardiol; 2013 Apr; 29(4):499-509. PubMed ID: 22926037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.
    Bennetzen MF; Wellner N; Ahmed SS; Ahmed SM; Diep TA; Hansen HS; Richelsen B; Pedersen SB
    Int J Obes (Lond); 2011 Nov; 35(11):1377-84. PubMed ID: 21326208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
    Kunos G
    Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.